G38R (p.Gly38Arg) variant of CDKN2A (Tumor suppressor ARF)

G38R (p.Gly38Arg) in CDKN2A (Tumor suppressor ARF) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Familial melanoma. The available variant effect predictions contribute to a CATVariant prioritization score of 0.36 / 1. The record also includes published literature.

G38R (p.Gly38Arg) variant details